為達最佳瀏覽效果,建議使用 Chrome、Firefox 或 Microsoft Edge 的瀏覽器。

請至Edge官網下載 請至FireFox官網下載 請至Google官網下載
晴時多雲

    限制級
    您即將進入之新聞內容 需滿18歲 方可瀏覽。
    根據「電腦網路內容分級處理辦法」修正條文第六條第三款規定,已於網站首頁或各該限制級網頁,依台灣網站分級推廣基金會規定作標示。 台灣網站分級推廣基金會(TICRF)網站:http://www.ticrf.org.tw

    《TAIPEI TIMES》 Local vaccines could be made in July: minister

    Chinese Nationalist Party (KMT) Legislator Charles Chen, right, gives bouquets of flowers to Premier Su Tseng-chang, front left, and Minister of Health and Welfare Chen Shih-chung during a legislative session in Taipei yesterday to thank them for their COVID-19 pandemic prevention efforts.
Photo: Chien Jung-fong, Taipei Times

    Chinese Nationalist Party (KMT) Legislator Charles Chen, right, gives bouquets of flowers to Premier Su Tseng-chang, front left, and Minister of Health and Welfare Chen Shih-chung during a legislative session in Taipei yesterday to thank them for their COVID-19 pandemic prevention efforts. Photo: Chien Jung-fong, Taipei Times

    2021/03/06 03:00

    SETTING AN EXAMPLE: If the public was hesitant in taking the AstraZeneca shot, the president and health minister would volunteer to demonstrate, Chen said

    / Staff writer, with CNA

    Taiwan’s domestically developed COVID-19 vaccines could start mass production in July, but only if they successfully complete ongoing clinical trials, Minister of Health and Welfare Chen Shih-chung (陳時中) said yesterday.

    Speaking to reporters before a legislative hearing in Taipei, Chen said that Taiwanese vaccines could hopefully enter production in July at the earliest.

    Taiwan is making progress in its vaccine development, after Medigen Vaccine Biologics Corp (高端疫苗) and United Biomedical Inc (聯亞生技) were approved to enter the second phase of clinical trials in late December last year and January respectively.

    Medigen in January said it planned to recruit at least 3,700 participants for trials, while working with 11 hospitals, on its vaccine, MVC-COV1901, which was developed with the US National Institutes of Health.

    The company received NT$1.7 million (US$60,122) in government subsidies for its phase 1 trials and was to receive another NT$300 million for its phase 2 trials.

    United Biomedical in late January said it would recruit 3,850 volunteers for phase 2 trials of its vaccine candidate, UB-612, a multitope protein/peptide-based vaccine.

    Asked whether President Tsai Ing-wen (蔡英文), Premier Su Tseng-chang (蘇貞昌) and Chen would be among the first to receive the AstraZeneca COVID-19 vaccine, Chen said that if there is any public hesitancy, they would be willing to volunteer to demonstrate the safety of the vaccine to those concerned about side effects.

    However, Chen said he hoped that the vaccination program would proceed in accordance with the government’s priority list.

    The minister’s comments came after 117,000 doses of the AstraZeneca COVID-19 vaccine, purchased directly from the company, arrived in Taiwan on Wednesday.

    No new COVID-19 cases were reported yesterday.

    To date, Taiwan has recorded 960 cases of COVID-19, 844 of which have been classified as imported. Of the total, 928 people have recovered, nine have died, and 23 are in hospital, according to CECC statistics.

    新聞來源:TAIPEI TIMES

    不用抽 不用搶 現在用APP看新聞 保證天天中獎  點我下載APP  按我看活動辦法

    焦點今日熱門

    網友回應

    此網頁已閒置超過5分鐘,請點擊透明黑底或右下角 X 鈕。